AntimicrobialInvestigational

Lactoferricin

Oral, Topical

Overview

Lactoferricin is a cationic antimicrobial peptide derived from pepsin-mediated cleavage of lactoferrin, an iron-binding glycoprotein found in milk and mucosal secretions. The most studied variant, bovine lactoferricin B, is a 25-amino acid peptide that disrupts microbial membranes and chelates iron, contributing to its broad-spectrum antimicrobial activity.

Mechanism of Action

Lactoferricin exhibits antibacterial, antifungal, antiviral, and antiparasitic properties, along with immunomodulatory effects. Its natural origin and multifunctional activity have generated interest in food preservation, oral health, and topical antimicrobial applications..

Research Summary & Key Findings

In vitro studies and animal models have demonstrated antimicrobial efficacy against a range of pathogens, including antibiotic-resistant strains. Small human trials have explored lactoferricin or lactoferrin-derived peptides in oral health applications such as periodontitis and dental caries prevention, with mixed results. Large-scale clinical development has been limited, and most applications remain in preclinical or early-phase investigation.

Clinical Status

Investigational

Lactoferricin is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

OralTopical

Related Peptides in Antimicrobial

Find a Provider

Find a verified provider who offers Lactoferricin therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Lactoferricin.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.